Society of General Internal Medicine

View all recommendations from this society

Released September 12, 2013; Revised January 31, 2017; Revised November 30, 2022

Don’t recommend daily home glucose monitoring in patients with Type 2 diabetes mellitus not using insulin.

Self-monitoring of blood glucose (SMBG) is an integral part of patient self-management in maintaining safe and target-driven glucose control in type 1 diabetes mellitus. However, for patients with type 2 diabetes mellitus who are not on insulin or medications associated with hypoglycemia, daily glucose monitoring has been shown to have small statistically significant, but not clinically important, changes in glucose control, and small, but significant, patient harms are associated with daily glucose monitoring. SMBG as part of a structured program of education and medication modification should be reserved for patients during the titration of their medication doses or during periods of changes in patients’ diet and exercise routines.

These items are provided solely for informational purposes and are not intended as a substitute for consultation with a medical professional. Patients with any specific questions about the items on this list or their individual situation should consult their physician.

How The List Was Created

An ad hoc committee of the Society of General Internal Medicine (SGIM) was impaneled, taking advantage of the clinical expertise of members from the Clinical Practice Committee and Evidence-Based Medicine Task Force within the Society. Members of the ad hoc committee were then solicited to determine possible topics for consideration. The topics chosen were selected to meet the goals of the Choosing Wisely campaign, utilizing the unique clinical perspective of members of the Society in ambulatory general medicine as well as hospital-based practice. The final topics were selected by a vote of committee members based on the strength of the existing evidence, the unique standing members of the Society have in addressing the clinical topics selected, as well as contributions the recommendations would make in terms of patient safety, quality and economic impact. The final recommendations were approved by the governing Council of SGIM.

For SGIM’s disclosure and conflict of interest policies, please visit


Chircop J, Sheffield D, Kotera Y. Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes. Nurs Res. 2021 Nov-Dec 01;70(6):487-497. doi: 10.1097/NNR.0000000000000542. PMID: 34292228.

Zhu H, Zhu Y, Leung S-w. Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials. BMJ Open 2016;6: e010524. doi:10.1136/ bmjopen-2015-010524

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977.

Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med 2005; 353: 26.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2013;36 Suppl 1:S11.

Pfoh ER, Linfield D, Speaker SL, Roufael JS, Yan C, Misra-Hebert AD, Rothberg MB. Patient Perspectives on Self-Monitoring of Blood Glucose When not Using Insulin: a Cross-sectional Survey. J Gen Intern Med. 2022 May;37(7):1673-1679. doi: 10.1007/s11606-021-07047-2.

Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006; 29:1757.

Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997; 20:1482.

Harris MI, National Health and Nutrition Examination Survey (NHANES III). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24:979.

Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006; 29:1764.

Franciosi M, Pellegrini F, De Berardis G, et al. Self-monitoring of blood glucose in noninsulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control.Diabet Med 2005; 22:900.

O’Kane MJ, Bunting B, Copeland M, et al. Efficacy of self-monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336:1174.

Peel E, Douglas M, Lawton J. Self-monitoring of blood glucose in type2 diabetes: longitudinal qualitative study of patients’ perspectives. BMJ. 2007; 335: 493.

Hou Y-Y, Wei L, Qiu L-B, Wang X-H. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: A meta-analysis. International Journal of Nursing Sciences 2014;1(2):191-195.

Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A.: Diabetes Glycaemic Education and Monitoring Trial Group Cost effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008; 336: 1177– 1180.

Davidson MB.: Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005; 28: 1531– 153.

Chamberlain JJ, Doyle-Delgado K, Peterson L, Skolnik N. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes. Annals of internal medicine. 2019;171(6):415-420. doi:10.7326/M19-1638.